Vitality Watch

Dossier rss preclinical 06-oct-2026
Animal model, organoid, or cell-culture result — not yet human

Aging Affects Pancreatic α‐Cell Function and Promotes Hyperglucagonemia: Implications in Age‐Associated Diabetes

Key claim: Aging impairs pancreatic α-cell function and promotes hyperglucagonemia, contributing to age-associated diabetes.

Abstract

Aging Cell, Volume 25, Issue 10, October 2026.

Why this matters

Most aging-and-diabetes mechanistic work centers on β-cell decline and insulin resistance; this finding foregrounds the α-cell and glucagon excess as a parallel driver, broadening the islet-aging picture. If it holds up in human tissue, it would reshape where geroscience-oriented diabetes interventions aim — toward glucagon suppression or α-cell rejuvenation rather than β-cell preservation alone. For now the claim sits at preclinical/mechanistic weight and has not been shown to translate to human outcomes.

Source

Link

Briefing card

Aging Affects Pancreatic α‐Cell Function and Promotes Hyperglucagonemia: Implications in Age‐Associated Diabetes
Stage: preclinical · rss · 06-oct-2026

If you follow age-associated diabetes mechanisms, this adds α-cell dysfunction and glucagon excess — not just β-cell failure — to the proposed causal picture, still at preclinical weight.

Aging impairs pancreatic α-cell function and promotes hyperglucagonemia, contributing to age-associated diabetes.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: url:https://onlinelibrary.wiley.com/doi/10.1111/acel.70753?af=R

build build 880 · 2bcef25 · 2026-11-18